Biophage appoints new board members
This article was originally published in Scrip
Executive Summary
Biophage Pharma (Canada) has appointed Mr Luc Dubois and Mr Jocelyn Pelchat to its board of directors. Mr Dubois is currently president of the board of Validapro Biosciences, and a biologist expert in the pharmaceutical and biotechnology fields, working on areas from process development to commercial product manufacturing. Dr Pelchat is vice-president of Pharma Concept, and has served in a number of executive, business development and management positions, with companies including Axcan Pharma, Sanofi-Aventis and Novartis.